Renal	renal	O	DISEASE	OTHERS	I
Fanconi	fanconi	O	DISEASE	OTHERS	I
syndrome	syndrome	O	DISEASE	OTHERS	I
and	and	O	O	O	O
myopathy	myopathy	O	DISEASE	OTHERS	I
after	after	O	O	O	O
liver	liver	O	O	O	O
transplantation	transplantation	O	O	O	O
:	:	O	O	O	O
drug-related	drug-related	O	O	O	O
mitochondrial	mitochondrial	O	O	O	O
cytopathy?Advances	cytopathy?advances	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
field	field	O	O	O	O
of	of	O	O	O	O
transplantation	transplantation	O	O	O	O
provide	provide	O	O	O	O
a	a	O	O	O	O
better	better	O	O	O	O
quality	quality	O	O	O	O
of	of	O	O	O	O
life	life	O	O	O	O
and	and	O	O	O	O
allow	allow	O	O	O	O
more	more	O	O	O	O
favorable	favorable	O	O	O	O
conditions	conditions	O	O	O	O
for	for	O	O	O	O
growth	growth	O	O	O	O
and	and	O	O	O	O
development	development	O	O	O	O
in	in	O	O	O	O
children	children	O	O	O	O
.	.	O	O	O	O

However	however	O	O	O	O
,	,	O	O	O	O
combinations	combinations	O	O	O	O
of	of	O	O	O	O
different	different	O	O	O	O
therapeutic	therapeutic	O	O	O	O
regimens	regimens	O	O	O	O
require	require	O	O	O	O
consideration	consideration	O	O	O	O
of	of	O	O	O	O
potential	potential	O	O	O	O
adverse	adverse	O	O	O	O
reactions	reactions	O	O	O	O
.	.	O	O	O	O

We	we	O	O	O	O
describe	describe	O	O	O	O
a	a	O	O	O	O
15-yr-old	15-yr-old	O	O	O	O
girl	girl	O	O	O	O
who	who	O	O	O	O
had	had	O	O	O	O
orthotopic	orthotopic	O	O	O	O
liver	liver	O	O	O	O
transplantation	transplantation	O	O	O	O
because	because	O	O	O	O
of	of	O	O	O	O
Wilson	wilson	O	DISEASE	OTHERS	I
's	's	O	DISEASE	OTHERS	I
disease	disease	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Tacrolimus	tacrolimus	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
MMF	mmf	O	O	OTHERS	I
,	,	O	O	O	O
and	and	O	O	O	O
steroids	steroids	CHEMICALS	O	OTHERS	I
were	were	O	O	O	O
given	given	O	O	O	O
as	as	O	O	O	O
immunosuppressant	immunosuppressant	O	O	O	O
.	.	O	O	O	O

Lamivudine	lamivudine	CHEMICALS	O	OTHERS	I
was	was	O	O	O	O
added	added	O	O	O	O
because	because	O	O	O	O
of	of	O	O	O	O
de	de	O	O	O	O
nova	nova	O	O	O	O
hepatitis	hepatitis	O	DISEASE	OTHERS	I
B	b	O	DISEASE	OTHERS	I
infection	infection	O	DISEASE	OTHERS	I
during	during	O	O	O	O
her	her	O	O	O	O
follow-up	follow-up	O	O	O	O
.	.	O	O	O	O

Three	three	O	O	O	O
yr	yr	O	O	O	O
after	after	O	O	O	O
transplantation	transplantation	O	O	O	O
she	she	O	O	O	O
developed	developed	O	O	O	O
renal	renal	O	DISEASE	OTHERS	I
Fanconi	fanconi	O	DISEASE	OTHERS	I
syndrome	syndrome	O	DISEASE	OTHERS	I
with	with	O	O	O	O
severe	severe	O	O	O	O
metabolic	metabolic	O	DISEASE	OTHERS	I
acidosis	acidosis	O	DISEASE	OTHERS	I
,	,	O	O	O	O
hypophosphatemia	hypophosphatemia	O	O	OTHERS	I
,	,	O	O	O	O
glycosuria	glycosuria	O	DISEASE	OTHERS	I
,	,	O	O	O	O
and	and	O	O	O	O
aminoaciduria	aminoaciduria	O	O	OTHERS	I
.	.	O	O	O	O

Although	although	O	O	O	O
tacrolimus	tacrolimus	CHEMICALS	O	OTHERS	I
was	was	O	O	O	O
suspected	suspected	O	O	O	O
to	to	O	O	O	O
be	be	O	O	O	O
the	the	O	O	O	O
cause	cause	O	O	O	O
of	of	O	O	O	O
late	late	O	O	O	O
post-transplant	post-transplant	O	O	O	O
renal	renal	O	O	O	O
acidosis	acidosis	O	DISEASE	OTHERS	I
and	and	O	O	O	O
was	was	O	O	O	O
replaced	replaced	O	O	O	O
by	by	O	O	O	O
sirolimus	sirolimus	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
acidosis	acidosis	O	DISEASE	OTHERS	I
,	,	O	O	O	O
and	and	O	O	O	O
electrolyte	electrolyte	O	O	O	O
imbalance	imbalance	O	O	O	O
got	got	O	O	O	O
worse	worse	O	O	O	O
.	.	O	O	O	O

Proximal	proximal	O	O	O	O
muscle	muscle	O	DISEASE	OTHERS	I
weakness	weakness	O	DISEASE	OTHERS	I
has	has	O	O	O	O
developed	developed	O	O	O	O
during	during	O	O	O	O
her	her	O	O	O	O
follow-up	follow-up	O	O	O	O
.	.	O	O	O	O

Fanconi	fanconi	O	DISEASE	OTHERS	I
syndrome	syndrome	O	DISEASE	OTHERS	I
,	,	O	O	O	O
as	as	O	O	O	O
well	well	O	O	O	O
as	as	O	O	O	O
myopathy	myopathy	O	DISEASE	OTHERS	I
,	,	O	O	O	O
is	is	O	O	O	O
well	well	O	O	O	O
recognized	recognized	O	O	O	O
in	in	O	O	O	O
patients	patients	O	O	O	O
with	with	O	O	O	O
mitochondrial	mitochondrial	O	O	OTHERS	I
disorders	disorders	O	O	OTHERS	I
and	and	O	O	O	O
caused	caused	O	O	O	O
by	by	O	O	O	O
depletion	depletion	O	O	O	O
of	of	O	O	O	O
mtDNA	mtdna	O	O	O	O
.	.	O	O	O	O

We	we	O	O	O	O
suggest	suggest	O	O	O	O
that	that	O	O	O	O
our	our	O	O	O	O
patient	patient	O	O	O	O
's	's	O	O	O	O
tubular	tubular	O	O	OTHERS	I
dysfunction	dysfunction	O	O	OTHERS	I
and	and	O	O	O	O
myopathy	myopathy	O	DISEASE	OTHERS	I
may	may	O	O	O	O
have	have	O	O	O	O
resulted	resulted	O	O	O	O
from	from	O	O	O	O
mitochondrial	mitochondrial	O	DISEASE	OTHERS	I
dysfunction	dysfunction	O	DISEASE	OTHERS	I
which	which	O	O	O	O
is	is	O	O	O	O
triggered	triggered	O	O	O	O
by	by	O	O	O	O
tacrolimus	tacrolimus	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
augmented	augmented	O	O	O	O
by	by	O	O	O	O
lamivudine	lamivudine	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

